As Walgreens Looks to Save Cash, Suitor Sycamore Seeks Funding
Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...
Crain's Chicago Business2d
As Walgreens looks to save cash, its private-equity suitor seeks funding
Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.
Drug Store News6d
Walgreens buyout talks reportedly unlikely to culminate in a deal
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...
Walgreens partly paring decline on report of Sycamore deal talks
Walgreens Boots ( NASDAQ: WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking to private equity confirms about debt financing for a potential takeover.
Walgreens sinks on report that Sycamore potential deal is likely dead
Walgreens Boots (WBA) falls 6.6% as potential takeover by Sycamore Partners unlikely to happen due to DOJ lawsuit over opioid prescriptions.
Why Walgreens Boots Alliance Stock Sank by Almost 5% Today
Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...
Walgreens Stock Tumbles. Report Says Private-Equity Bid for Pharmacy Chain ‘Mostly Dead.’
The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...
Why WBA Is Plunging Today
Walgreens Boots Alliance (WBA) is tumbling 11% in early trading. The sharp downturn comes after the company announced ...
Walgreens Stock Slides on Dividend Suspension
Shares of Walgreens Boots Alliance dropped 10% Friday, after the pharmacy chain suspended quarterly dividends, citing the need for cash amid litigation and turnaround efforts. The Justice Department t ...
Walgreens Boots slides after CNBC’s Faber calls Sycamore deal ‘mostly dead’
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...